Fig. 5.
Expression (A) and enhanced kinase activity (B) of the p210bcr/abl transgene product in the thymi of the two founder mice, 4-3 and 4-5 that developed ALLs. The expressed and phosphorylated p210bcr/abl transgene products are indicated by arrows and the positions of protein markers are shown on the left. The thymi of nontransgenic mice were used as negative controls (C).

Expression (A) and enhanced kinase activity (B) of the p210bcr/abl transgene product in the thymi of the two founder mice, 4-3 and 4-5 that developed ALLs. The expressed and phosphorylated p210bcr/abl transgene products are indicated by arrows and the positions of protein markers are shown on the left. The thymi of nontransgenic mice were used as negative controls (C).

Close Modal

or Create an Account

Close Modal
Close Modal